Full Press Release Details
DUBLIN , May 24, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that the company will host a webcast to discuss data to be presented on solriamfetol (JZP-110) and Xyrem® (sodium oxybate) oral solution at the Annual Meeting of the Associated Professional Sleep Societies (APSS) in Baltimore, MD from June 3-6, 2018.
The live webcast will begin at 7:00 p.m. EDT on June 5, 2018 . Interested parties may access the live audio webcast via the Investors section of the Jazz Pharmaceuticals website at http://www.jazzpharmaceuticals.com . Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast.
Audio webcast/conference call: U.S. dial-in number: +1 800 239 9838 International dial-in numbers: click here Passcode: 5629915
An audio archive of the webcast will be available for at least one week following the presentation on the Investors section of the company's website at http://www.jazzpharmaceuticals.com .
SOURCE Jazz Pharmaceuticals plc